SPIT, Maureen, Nicola FENDERICO, Ingrid JORDENS, Tomasz Witold RADASZKIEWICZ, Rik G. H. LINDEBOOM, Jeroen M. BUGTER, Alba CRISTOBAL, Lars OOTES, Max VAN OSCH, Eline JANSSEN, Kim E. BOONEKAMP, Kateřina HANÁKOVÁ, David POTĚŠIL, Zbyněk ZDRÁHAL, Sylvia F. BOJ, Jan Paul MEDEMA, Vítězslav BRYJA, Bon-Kyoung KOO, Michiel VERMEULEN and Madelon M. MAURICE. RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer. EMBO Journal. Hoboken (USA): Wiley, 2020, vol. 39, No 18, p. 1-15. ISSN 0261-4189. Available from: https://dx.doi.org/10.15252/embj.2019103932.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer
Authors SPIT, Maureen, Nicola FENDERICO, Ingrid JORDENS, Tomasz Witold RADASZKIEWICZ (616 Poland, belonging to the institution), Rik G. H. LINDEBOOM, Jeroen M. BUGTER, Alba CRISTOBAL, Lars OOTES, Max VAN OSCH, Eline JANSSEN, Kim E. BOONEKAMP, Kateřina HANÁKOVÁ (203 Czech Republic, belonging to the institution), David POTĚŠIL (203 Czech Republic, belonging to the institution), Zbyněk ZDRÁHAL (203 Czech Republic, belonging to the institution), Sylvia F. BOJ, Jan Paul MEDEMA, Vítězslav BRYJA (203 Czech Republic, belonging to the institution), Bon-Kyoung KOO, Michiel VERMEULEN and Madelon M. MAURICE.
Edition EMBO Journal, Hoboken (USA), Wiley, 2020, 0261-4189.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 11.598
RIV identification code RIV/00216224:14310/20:00114578
Organization unit Faculty of Science
Doi http://dx.doi.org/10.15252/embj.2019103932
UT WoS 000557439600001
Keywords in English cancer mutations; human colon organoids; PORCNinhibitors; RNF43; Wnt signaling
Tags CF PROT, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 20/4/2021 16:52.
Abstract
Wnt/beta-catenin signaling is a primary pathway for stem cell maintenance during tissue renewal and a frequent target for mutations in cancer. Impaired Wnt receptor endocytosis due to loss of the ubiquitin ligaseRNF43 gives rise to Wnt-hypersensitive tumors that are susceptible to anti-Wnt-based therapy. Contrary to this paradigm, we identify a class ofRNF43 truncating cancer mutations that induce beta-catenin-mediated transcription, despite exhibiting retained Wnt receptor downregulation. These mutations interfere with a ubiquitin-independent suppressor role of theRNF43 cytosolic tail that involves Casein kinase 1 (CK1) binding and phosphorylation. Mechanistically, truncatedRNF43 variants trapCK1 at the plasma membrane, thereby preventing beta-catenin turnover and propelling ligand-independent target gene transcription. Gene editing of human colon stem cells shows thatRNF43 truncations cooperate with p53 loss to drive a niche-independent program for self-renewal and proliferation. Moreover, theseRNF43 variants confer decreased sensitivity to anti-Wnt-based therapy. Our data demonstrate the relevance of studying patient-derived mutations for understanding disease mechanisms and improved applications of precision medicine.
Links
GX19-28347X, research and development projectName: Molekulární a funkční analýza biologie kasein kinázy 1
Investor: Czech Science Foundation
LM2018127, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 11/5/2024 06:05